AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:48AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 219.13B |
| Enterprise Value | 241.89B |
| Trailing P/E | 37.38 |
| Forward P/E | 16.89 |
| PEG Ratio (5 yr expected) | 0.91 |
| Price/Sales (ttm) | 4.86 |
| Price/Book (mrq) | 5.64 |
| Enterprise Value/Revenue | 5.28 |
| Enterprise Value/EBITDA | 18.02 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.19 |
| 52-Week Change 3 | -3.50% |
| S&P500 52-Week Change 3 | 22.64% |
| 52 Week High 3 | 75.81 |
| 52 Week Low 3 | 60.47 |
| 50-Day Moving Average 3 | 66.62 |
| 200-Day Moving Average 3 | 66.71 |
Share Statistics
| Avg Vol (3 month) 3 | 6.21M |
| Avg Vol (10 day) 3 | 5.93M |
| Shares Outstanding 5 | 3.1B |
| Implied Shares Outstanding 6 | 3.12B |
| Float 8 | 1.54B |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 16.84% |
| Shares Short (Apr 15, 2024) 4 | 8.58M |
| Short Ratio (Apr 15, 2024) 4 | 1.61 |
| Short % of Float (Apr 15, 2024) 4 | N/A |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.28% |
| Shares Short (prior month Mar 15, 2024) 4 | 10.48M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 1.45 |
| Forward Annual Dividend Yield 4 | 2.04% |
| Trailing Annual Dividend Rate 3 | 2.90 |
| Trailing Annual Dividend Yield 3 | 4.07% |
| 5 Year Average Dividend Yield 4 | 2.52 |
| Payout Ratio 4 | 76.12% |
| Dividend Date 3 | Mar 25, 2024 |
| Ex-Dividend Date 4 | Feb 22, 2024 |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Jul 27, 2015 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 13.00% |
| Operating Margin (ttm) | 16.92% |
Management Effectiveness
| Return on Assets (ttm) | 6.60% |
| Return on Equity (ttm) | 15.64% |
Income Statement
| Revenue (ttm) | 45.81B |
| Revenue Per Share (ttm) | 2.45 |
| Quarterly Revenue Growth (yoy) | 7.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | 15.01B |
| Net Income Avi to Common (ttm) | 5.95B |
| Diluted EPS (ttm) | 1.91 |
| Quarterly Earnings Growth (yoy) | 6.50% |
Balance Sheet
| Total Cash (mrq) | 5.86B |
| Total Cash Per Share (mrq) | 3.78 |
| Total Debt (mrq) | 29.65B |
| Total Debt/Equity (mrq) | 75.70% |
| Current Ratio (mrq) | 0.82 |
| Book Value Per Share (mrq) | 25.25 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 10.34B |
| Levered Free Cash Flow (ttm) | 9.5B |
© 2024 Yahoo. All rights reserved.